Come to booth 2313 at the AUA Annual Meeting in Orlando, May 17-22

Find out where in the world your votes sent the "BPH Boys" and how you can help advance urological research by participating in booth activities.

Where would you like to go next? Interactive FLOMAX eDetail AUA '08 Learn More About FLOMAX

The AUA Foundation does not endorse any urological or other products.

Important Safety Information
FLOMAX is indicated to treat the signs and symptoms of benign prostatic hyperplasia (BPH). FLOMAX is not indicated to treat hypertension. As with other alpha-adrenergic blocking agents, there is a potential risk of syncope. Patients beginning treatment with FLOMAX should be cautioned to avoid situations where injury could result should syncope occur. The most common side effects are dizziness, abnormal ejaculation, and rhinitis.

Caution should be exercised with concomitant administration of warfarin and FLOMAX. In addition, FLOMAX should be used with caution in combination with cimetidine, particularly at doses higher than 0.4 mg. FLOMAX is contraindicated in patients known to be hypersensitive to tamsulosin HCl or any component of FLOMAX.

Before prescribing FLOMAX, please see the full Prescribing Information.

Terms of Use | Privacy Policy | Contact Us | Print This Page | Return to URO Page
Boehringer Ingelheim - astellas The information provided on this site is intended only for healthcare professionals licensed and practicing in the United States.